Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.-论文-万方医学网

第一作者： Anastasios,Stathis

第一单位： Clinical Research Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. anastasios.stathis@eoc.ch cfrench@partners.org.

作者： Anastasios,Stathis ^[1] ; Emanuele,Zucca ^[2] ; Mohamed,Bekradda ^[3] ; Carlos,Gomez-Roca ^[4] ; Jean-Pierre,Delord ^[4] ; Thibault,de La Motte Rouge ^[5] ; Emmanuelle,Uro-Coste ^[6] ; Filippo,de Braud ^[7] ; Giuseppe,Pelosi ^[8] ; Christopher A,French ^[9]

作者单位： Clinical Research Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. anastasios.stathis@eoc.ch cfrench@partners.org. ^[1] Clinical Research Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. ^[2] Oncology Therapeutic Development, Clichy, France. ^[3] Clinical Research Unit, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. ^[4] Institut Curie, Hôpital René Huguenin, Saint Cloud, France. ^[5] Department of Pathology, Toulouse University Hospital and INSERM U1037, IUCT-Oncopole, Toulouse, France. ^[6] Department of Medical Oncology, Fondazione IRCCS Istituto Tumori Milano, Department of Oncology, Università degli Studi di Milano, Milan, Italy. ^[7] Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori and Department of Biological and Clinical Sciences "Luigi Sacco," Università degli Studi, Milan, Italy. ^[8] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. anastasios.stathis@eoc.ch cfrench@partners.org. ^[9]

医学主题词乙酰苯胺类(Acetanilides);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);活组织检查(Biopsy);癌(Carcinoma);细胞系, 肿瘤(Cell Line, Tumor);致命性结局(Fatal Outcome);女(雌)性(Female);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);人类(Humans);原位杂交, 荧光(In Situ Hybridization, Fluorescence);男(雄)性(Male);分子靶向治疗(Molecular Targeted Therapy);肿瘤分期(Neoplasm Staging);核蛋白质类(Nuclear Proteins);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1158/2159-8290.CD-15-1335

PMID 26976114

发布时间 2023-11-11

检索历史清除

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.

Cancer discovery

相似文献

同项目论文

Cancer discovery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.

Cancer discovery

相似文献

同项目论文

Cancer discovery

相关期刊

检索历史清除